Related Experiment Video
Updated: Jun 12, 2026
03:53
Extracellular Vesicle Tissue Factor Activity Assay
Published on: December 29, 2023
Tissue factor and thrombosis: The clot starts here
A Phillip Owens1, Nigel Mackman
1Division of Hematology/Oncology, Department of Medicine, University of North Carolina at Chapel Hill, USA.
Thrombosis and Haemostasis
|June 12, 2010
Summary
Thrombosis is a leading cause of death. This review explores how animal models and tissue factor (TF) research can help develop new antithrombotic drugs to combat clot formation and its severe consequences.
Area of Science:
- Cardiovascular Science
- Hematology
- Pharmacology
Background:
- Thrombosis is a major global health concern, ranking among the top three cardiovascular causes of death.
- Current antithrombotic therapies have limitations in safety and efficacy.
- Tissue factor (TF) is crucial for initiating blood coagulation and implicated in arterial and venous thrombosis.
Purpose of the Study:
- To review the role of tissue factor (TF) in various in vivo models of thrombosis.
- To highlight the importance of TF in understanding clot formation.
- To inform the development of novel antithrombotic strategies.
Main Methods:
- Review of existing literature on TF and thrombosis.
- Analysis of data from various animal models of thrombosis.
- Focus on in vivo studies investigating TF's role.
Main Results:
- Tissue factor (TF) is essential for the initiation of coagulation.
- TF plays a significant role in both arterial and venous thrombosis.
- In vivo models are critical for studying thrombosis mechanisms.
Conclusions:
- Understanding TF's function in thrombosis is key to developing new treatments.
- Targeting TF may offer a promising approach for novel antithrombotic drugs.
- Continued research using animal models is vital for advancing thrombosis treatment.
Related Concept Videos
01:20Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
01:16Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
01:09Coagulation
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
01:06Coagulation
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...